Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage

NCT06267170 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.

NCT NCT06267170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06267170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage
Lead sponsor
Henan Cancer Hospital
Phase
Observational
Overall status
Unknown status
Start date
February 25, 2024
Completion date
February 25, 2026
Enrollment
288 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sclc,extensive stage